phencyclidine has been researched along with Psychotic Disorders in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (18.18) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 10 (30.30) | 29.6817 |
| 2010's | 9 (27.27) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Delgado-Sallent, C; Fath, AB; Gener, T; Nebot, P; Puig, MV; Timplalexi, M | 1 |
| Artigas, F; Castañé, A; Castarlenas, L; Fabius, S; López-Hill, X; Miquel-Rio, L; Santana, N; Scorza, MC; Tarrés-Gatius, M; Vilaró, MT | 1 |
| Barrera-Conde, M; Bergé, D; de la Torre, R; Garcia-Quintana, J; Gomis-Gonzalez, M; Martínez-Sadurní, L; Perez, V; Pujades, M; Robledo, P; Trabsa, A; Veza-Estévez, E | 1 |
| Bhat, L; Cantillon, M; Huang, M; Kwon, S; Meltzer, HY; Michael, E; Rajagopal, L | 1 |
| de la Fuente Revenga, M; Dunn, CM; González-Maeso, J; Hideshima, KS; Hojati, A; Miles, MF; On, DM; Pais, AB; Pais, AC; Sánchez-González, A; Saunders, JM; Shin, JM; Wolstenholme, JT | 1 |
| Khattak, HZ; Lee, JL; Richardson, L; Vreugdenhil, M; Ward, KC | 1 |
| Jodo, E | 1 |
| Fukunari, A; Kajii, Y; Kano, S; Kondo, MA; Miwa, K; Ohzeki, H; Okada, K; Sakaue, M; Sawa, A; Takemoto, K; Tamura, M; Tezuka, T; Yasumatsu, H | 1 |
| Antonelli, T; Beggiato, S; Ferraro, L; Parolaro, D; Prini, P; Rubino, T; Steardo, L; Zamberletti, E | 1 |
| Bahn, S; Cooper, JD; Cox, DA; Ernst, A; Gottschalk, MG; Wesseling, H | 1 |
| Bach, JH; Jung, BD; Kim, HC; Kim, JM; Kim, S; Nabeshima, T; Nguyen, TT; Nguyen, XK; Shin, EJ; Whang, WK; Yamada, K | 1 |
| Hammond, B; Hussain, I; Kew, JN; Stean, TO; Upton, N; Virley, DJ; Waters, KA | 1 |
| WEISCHEDEL, D; ZIOLKO, HU | 1 |
| KODAMA, M | 1 |
| IRANYI, J | 1 |
| Cochran, SM; Morris, BJ; Pratt, JA; Reynolds, GP; Reynolds, LM | 1 |
| Bhardwaj, SK; Boksa, P; El-Ghundi, M; George, SR; Grandy, DK; Männistö, PT; O'dowd, BF; Palmiter, RD; Perreault, ML; Premont, RT; Quirion, R; Robinson, S; Seeman, P; Sotnikova, TD; Srivastava, LK; Tallerico, T; Weinshenker, D | 1 |
| Barda, D; Britton, TC; Emkey, R; Hornback, WJ; Jagdmann, GE; Johnson, MP; McKinzie, DL; Nisenbaum, ES; Schoepp, DD; Tizzano, JP | 1 |
| Bachs, L; Hjelmeland, K; Høiseth, G | 1 |
| Carls, KA; Ruehter, VL | 1 |
| Fernández, AS; López-García, P; Navarro, JS; Sádaba, B; Santos, PM; Vidal, JP | 1 |
| Hendren, RL; Sharp, FR | 1 |
| Davis, JM; Schlemmer, RF | 1 |
| de Montigny, C; Debonnel, G | 1 |
| Alim, TN; Collins, JP; Deutsch, SI; Fay-McCarthy, M; Rosse, RB; Wyatt, RJ | 1 |
| Barber, DJ; Cooper, AJ; Griffiths, MR; Mitchell, IJ | 1 |
| Sams-Dodd, F | 1 |
| Danysz, W; Karcz-Kubicha, M; Wedzony, K; Zajaczkowski, W | 1 |
| Kanazir, S; Rakic, L; Ruzdijic, S; Veskov, R; Vukosavic, S | 1 |
| Balakrishnan, S; Gupta, M; Pandhi, P | 1 |
| Gotoh, L; Hirano, M; Hondo, H; Kanchiku, I; Kawanami, N; Kuroki, T; Motomura, K; Nakahara, T; Ohta, E; Uchimura, H | 1 |
| Dorn, JM; Dubin, WR; Weiss, KJ | 1 |
| Gershon, S; Neubauer, H; Sundland, DM | 1 |
6 review(s) available for phencyclidine and Psychotic Disorders
| Article | Year |
|---|---|
The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia.
Topics: Animals; Disease Models, Animal; Hippocampus; Humans; Phencyclidine; Prefrontal Cortex; Psychotic Disorders; Rats; Schizophrenia | 2013 |
[Phencyclidine--angel dust].
Topics: Diagnosis, Differential; Hallucinogens; Humans; Phencyclidine; Phencyclidine Abuse; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2005 |
Psychosis: atypical limbic epilepsy versus limbic hyperexcitability with onset at puberty?
Topics: Adolescent; Animals; Antipsychotic Agents; Dizocilpine Maleate; Epilepsy; Excitatory Amino Acid Antagonists; Hallucinogens; Humans; Ketamine; Limbic System; Neurons; Phencyclidine; Psychoses, Substance-Induced; Psychotic Disorders; Puberty; Rats; Regional Blood Flow; Sexual Maturation | 2007 |
Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders.
Topics: Animals; Central Nervous System; Dopamine; Humans; Mental Disorders; N-Methylaspartate; Neuropeptides; Phencyclidine; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate; Receptors, Phencyclidine; Receptors, sigma; Steroids; Synaptic Transmission | 1996 |
Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity.
Topics: Animals; Antipsychotic Agents; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Neural Networks, Computer; Phencyclidine; Psychotic Disorders; Rats; Reproducibility of Results; Schizophrenia; Social Behavior Disorders; Stereotyped Behavior | 1999 |
Pharmacotherapy of psychiatric emergencies.
Topics: Amphetamines; Antipsychotic Agents; Anxiety Disorders; Basal Ganglia Diseases; Cocaine; Emergencies; Humans; Injections, Intramuscular; Phencyclidine; Psychotic Disorders; Substance-Related Disorders | 1986 |
1 trial(s) available for phencyclidine and Psychotic Disorders
| Article | Year |
|---|---|
Sernyl, ditran, and their antagonists: succinate and THA.
Topics: Acridines; Adult; Anesthetics; Bipolar Disorder; Brain Diseases; Clinical Trials as Topic; Drug Antagonism; Female; Hallucinogens; Humans; Male; Middle Aged; Phencyclidine; Psychotic Disorders; Schizophrenia; Succinates | 1966 |
26 other study(ies) available for phencyclidine and Psychotic Disorders
| Article | Year |
|---|---|
Atypical, but Not Typical, Antipsychotic Drugs Reduce Hypersynchronized Prefrontal-Hippocampal Circuits during Psychosis-Like States in Mice: Contribution of 5-HT2A and 5-HT1A Receptors.
Topics: Animals; Antipsychotic Agents; Clozapine; Haloperidol; Hippocampus; Mice; Phencyclidine; Prefrontal Cortex; Psychotic Disorders; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Risperidone; Serotonin Antagonists | 2022 |
Discrimination of motor and sensorimotor effects of phencyclidine and MK-801: Involvement of GluN2C-containing NMDA receptors in psychosis-like models.
Topics: Animals; Dizocilpine Maleate; GABAergic Neurons; Mice; Mice, Knockout; N-Methylaspartate; Phencyclidine; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate | 2022 |
Role of cyclin-dependent kinase 5 in psychosis and the modulatory effects of cannabinoids.
Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoids; Cyclin-Dependent Kinase 5; Disks Large Homolog 4 Protein; Mice; Phencyclidine; Psychotic Disorders; Schizophrenia | 2023 |
RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia.
Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Cerebral Cortex; Conditioning, Operant; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Male; Memory; Mice, Inbred C57BL; Motor Activity; Neurotransmitter Agents; Phencyclidine; Psychotic Disorders; Random Allocation; Reversal Learning; Schizophrenia; Schizophrenic Psychology | 2017 |
Role of mGlu2 in the 5-HT
Topics: Animals; Antipsychotic Agents; Clozapine; Frontal Lobe; Male; Mice; Mice, Knockout; Phencyclidine; Psychomotor Agitation; Psychotic Disorders; Receptor, Serotonin, 5-HT2A; Receptors, Metabotropic Glutamate; Schizophrenia | 2018 |
NMDA receptor antagonists distort visual grouping in rats performing a modified two-choice visual discrimination task.
Topics: Animals; Choice Behavior; Discrimination Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Impulsive Behavior; Ketamine; Male; Memory; Phencyclidine; Psychometrics; Psychotic Disorders; Rats; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior; Visual Perception | 2013 |
Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis.
Topics: Animals; Astrocytes; Brain; Central Nervous System Stimulants; Chelating Agents; Copper; Cuprizone; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hallucinogens; Hyperkinesis; Interleukin-6; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Phencyclidine; Psychotic Disorders; Time Factors | 2013 |
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats.
Topics: Age Factors; Animals; Animals, Newborn; Cannabinoid Receptor Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Motor Activity; Phencyclidine; Prefrontal Cortex; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Stereotyped Behavior; Synaptic Transmission | 2014 |
Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology.
Topics: Animals; Chromatography, Liquid; Disease Models, Animal; Humans; Ketamine; Machine Learning; Male; Mice, Transgenic; Phencyclidine; Prefrontal Cortex; Protein Interaction Maps; Proteomics; Psychotic Disorders; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Tandem Mass Spectrometry | 2016 |
Parishin C attenuates phencyclidine-induced schizophrenia-like psychosis in mice: involvements of 5-HT1A receptor.
Topics: Animals; Citrates; Glucosides; Mice; Phencyclidine; Psychotic Disorders; Receptor, Serotonin, 5-HT1A; Schizophrenia | 2010 |
Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognition.
Topics: Amphetamine; Animals; Animals, Outbred Strains; Cognition; Disease Models, Animal; Fluorobenzenes; Locomotion; Male; Phencyclidine; Phenols; Piperidines; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Recognition, Psychology; Serotonin Antagonists; Sulfonamides | 2012 |
[STUDIES WITH 1-(1'-PHENYLCYCLOHEXYL)-PIPERIDINE].
Topics: Anesthetics; Diagnosis, Differential; Hallucinogens; Humans; Neurotic Disorders; Phencyclidine; Piperidines; Psychopharmacology; Psychotic Disorders | 1964 |
[EXPERIMENTAL PSYCHOSIS INDUCED BY SERNYL (1-(1-PHENYLCYCLOHEXYL) PIPERIDINE. HC1)].
Topics: Anesthetics; Brain Chemistry; Pharmacology; Phencyclidine; Piperidines; Psychoses, Substance-Induced; Psychotic Disorders; Toxicology | 1964 |
[MODEL PSYCHOSIS CAUSED BY ELYSION].
Topics: Anesthetics; Euphoria; Hallucinations; Humans; Mental Disorders; Pharmacology; Phencyclidine; Psychotic Disorders; Toxicology | 1965 |
Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain.
Topics: Animals; Aspartic Acid; Brain; Chromatography, High Pressure Liquid; Corpus Striatum; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Frontal Lobe; Hallucinogens; Hippocampus; Male; Phencyclidine; Psychotic Disorders; Rats; Rats, Long-Evans; Temporal Lobe | 2005 |
Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis.
Topics: Animals; Catechol O-Methyltransferase; Corpus Striatum; Dopamine; Dopamine beta-Hydroxylase; Male; Phencyclidine; Psychotic Disorders; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, G-Protein-Coupled | 2005 |
Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s).
Topics: Animals; Anxiety; Cyclopropanes; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Glycine; Humans; Male; Mice; Mice, Inbred DBA; Mice, Inbred ICR; Motor Activity; Phencyclidine; Psychotic Disorders; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Synaptic Transmission | 2005 |
An evaluation of phencyclidine (PCP) psychosis: a retrospective analysis at a state facility.
Topics: Adult; Antipsychotic Agents; Cannabis; Hallucinogens; Humans; Length of Stay; Missouri; Phencyclidine; Psychotic Disorders; Retrospective Studies | 2006 |
False positive phencyclidine results caused by venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Drug Interactions; False Positive Reactions; Female; Humans; Middle Aged; Phencyclidine; Phencyclidine Abuse; Psychotic Disorders; Substance Abuse Detection; Venlafaxine Hydrochloride | 2007 |
A comparison of three psychotomimetic-induced models of psychosis in nonhuman primate social colonies.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Female; Hallucinogens; Humans; Macaca; Phencyclidine; Psychotic Disorders | 1983 |
Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective study.
Topics: Adult; Cocaine; Hallucinogens; Humans; Male; Narcotics; Phencyclidine; Psychoses, Substance-Induced; Psychotic Disorders; Retrospective Studies; Schizophrenia; Substance-Related Disorders | 1994 |
Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: a neural substrate for psychosis?
Topics: Animals; Apoptosis; Brain; Corpus Striatum; Dexamethasone; Glucocorticoids; Male; Neurons; Organ Specificity; Phencyclidine; Psychotic Disorders; Rats; Rats, Sprague-Dawley | 1998 |
NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity.
Topics: 2-Amino-5-phosphonovalerate; Amphetamine; Animals; Antimetabolites; Antipsychotic Agents; Binding Sites; Cycloleucine; Cycloserine; Disease Models, Animal; Dopamine Agents; Drug Synergism; Excitatory Amino Acid Antagonists; Glycine; Hallucinogens; Locomotion; Male; Phencyclidine; Phthalazines; Protein Structure, Tertiary; Psychotic Disorders; Pyrrolidinones; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Reflex, Startle | 1999 |
Differential effects of amphetamine and phencyclidine on the expression of growth-associated protein GAP-43.
Topics: Amphetamine; Animals; Biomarkers; Brain; Disease Models, Animal; Dopamine Agents; Dopamine Antagonists; Drug Administration Schedule; Excitatory Amino Acid Antagonists; GAP-43 Protein; Haloperidol; Male; Neostriatum; Neurons; Phencyclidine; Psychoses, Substance-Induced; Psychotic Disorders; Rats; Rats, Inbred Strains; RNA, Messenger | 2001 |
Role of nitric oxide in experimental models of psychosis in rats.
Topics: Animals; Arginine; Avoidance Learning; Catalepsy; Female; Male; Nitric Oxide; Nitroarginine; Phencyclidine; Psychotic Disorders; Rats; Stereotyped Behavior | 2001 |
Effects of the adenosine A(1) receptor agonist N(6)-cyclopentyladenosine on phencyclidine-induced behavior and expression of the immediate-early genes in the discrete brain regions of rats.
Topics: Adenosine; Animals; Antipsychotic Agents; Brain; Cytoskeletal Proteins; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression; Genes, Immediate-Early; Gyrus Cinguli; Hallucinogens; Head Movements; Male; Motor Activity; Nerve Tissue Proteins; Nucleus Accumbens; Phencyclidine; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Psychotic Disorders; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; RNA, Messenger | 2002 |